2 completed, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Recruiting 1 |
Follow Fontan: new trials by email Literature Review of Fontan trials Research Report on Fontan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure Dapagliflozin (5-10 mg daily) - SGLT2 Inhibitor Therapy - Fontan, Heart Failure | Phase 4 | Recruiting | The University of Hong Kong | 30 | 2026-07-01 | 2026-07-28 |
| TRPV2 Agonists in the Fontan Circulation Probenecid, Placebo - Fontan | Phase 4 | Completed | Children's Hospital Medical Center, Cincinnati | 8 | 2017-03-21 | 2021-07-09 |
| Effect of Carvedilol on Exercise Performance in Fontan Patients Carvedilol, Placebo - Single Ventricle, Fontan | Phase 4 | Completed | University of Texas Southwestern Medical Center | 26 | 2016-11-01 | 2021-01-22 |
Cardiovascular Diseases (1) · Heart Defects, Congenital (1) · Heart Failure (1) · Univentricular Heart (1)
Cardiovascular Abnormalities (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Heart Diseases (2) · Cardiovascular Diseases (1) · Heart Defects, Congenital (1)
Carvedilol (1) · Probenecid (1) · dapagliflozin (1)
Children's Hospital Medical Center, Cincinnati (1) · The University of Hong Kong (1) · University of Texas Southwestern Medical Center (1)
United States (2) · Hong Kong (1)